Wordt geladen...
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic (DAergic) neurons in the substantia nigra and the gradual depletion of dopamine (DA). Current treatments replenish the DA deficit and improve symptoms but induce dyskinesias over time, and...
Bewaard in:
| Gepubliceerd in: | Proc Natl Acad Sci U S A |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
National Academy of Sciences
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5393203/ https://ncbi.nlm.nih.gov/pubmed/28348207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1616874114 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|